Loading data
ABEONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5.82 m USD | — | 3.5 m USD | 1.41 m USD | 3 m USD |
| Cost of revenue | 1.53 m USD | — | — | — | — |
| Research and development expense | 26.81 m USD | 34.36 m USD | 31.09 m USD | 28.97 m USD | 38.73 m USD |
| Selling, general and administrative expense | 65.03 m USD | 29.85 m USD | — | — | — |
| Operating profit | -89.45 m USD | -64.21 m USD | -47.14 m USD | -50.92 m USD | -89.84 m USD |
| Interest expense | 3.74 m USD | 4.21 m USD | 418 k USD | 736 k USD | 3.66 m USD |
| Profit before tax | 71.28 m USD | -63.73 m USD | — | — | — |
| Income tax expense | 100 k USD | — | — | — | — |
| Net income (reported basis) | -71.18 m USD | 63.73 m USD | 54.19 m USD | 39.7 m USD | -84.94 m USD |
| Net income attributable to common shareholders | — | -63.7 m USD | -54.2 m USD | -43.5 m USD | -84.94 m USD |
| Basic earnings per share | 1.34 USD/share | -1.55 USD/share | -2.53 USD/share | -5.53 USD/share | -21.57 USD/share |
| Diluted earnings per share | 1.01 USD/share | -1.55 USD/share | -2.53 USD/share | -5.53 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.